Integrin Function in Cartilage
Integrin Function in Cartilage
批准号:
8402708
负责人:
RICHARD F LOESER
金额:
$42.02万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2017-07-31
关键词:
ADAMTSArthritisAutomobile DrivingBiologyCartilageCartilage MatrixCellsChemicalsChondrocytesChronicCollagenDegenerative polyarthritisDevelopmentDisease ProgressionElderlyEpidermal Growth FactorEpidermal Growth Factor ReceptorEventExhibitsExtracellular MatrixExtracellular Matrix ProteinsFamily memberFibronectinsFundingGoalsGrowth FactorGrowth Factor InhibitionHeparin BindingHistologicIn VitroInflammatoryInformation NetworksIntegrinsJUN geneKnockout MiceMAPK8 geneMAPK9 geneMatrix MetalloproteinasesMeasuresMedial meniscus structureMediatingMediator of activation proteinMitogen-Activated Protein Kinase 9Mitogen-Activated Protein KinasesModelingMolecularMonomeric GTP-Binding ProteinsMusMutationOperative Surgical ProceduresOxidantsOxidation-ReductionPhenotypePhosphorylationPhosphotransferasesPositioning AttributePost-Translational Protein ProcessingProductionProtein FragmentProteoglycanProteomicsReactive Oxygen SpeciesReducing AgentsRegulationRoleSecond Messenger SystemsSeveritiesSignal PathwaySignal TransductionSiteStaining methodStainsSulfenic AcidsTechniquesTestingWild Type MouseWorkbasecollagenase 3cysteinesulfenic acidcytokinedimerdisabilitydisulfide bondin vivoinhibitor/antagonistinnovationnew therapeutic targetnovelpreventreceptorresponsesecond messengersmall molecule
中文摘要
描述(由申请人提供):该项目的长期目标是确定整合素受体产生的信号调节软骨细胞功能的基本机制。推动这项工作的总体假设是,软骨细胞外基质(ECM)的变化,包括ECM蛋白片段的产生,被软骨细胞整合素识别,并启动一系列旨在重塑ECM的事件,但在关节炎中导致进一步的基质破坏(“软骨细胞软骨溶解”)。这里的重点是
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of this project is to determine the basic mechanisms by which signals generated through integrin receptors regulate chondrocyte function. The overall hypothesis driving this work is that changes in the cartilage extracellular matrix (ECM), including production of ECM protein fragments, are recognized by chondrocyte integrins and initiate a cascade of events intended to remodel the ECM but which in arthritis result in further matrix destruction ("chondrocytic chondrolysis"). The focus of this
proposal is to determine the basic cellular mechanisms that control signals generated through the ?5?1 integrin which regulate production of catabolic mediators including cytokines and matrix metalloproteinases (MMPs). During the previous funding period, we have defined the signaling pathways that mediate MMP-13 production in response to fibronectin fragment (FN-f) stimulation of the ?5?1integrin and discovered reactive oxygen species (ROS) are necessary second messengers. Using an innovative proteomics approach we found that the MAP kinase family member JNK2 is oxidized in FN-f stimulated cells forming a Cys-SOH (sulfenic acid) intermediate. Sulfenic acid formation serves as a major mechanism by which ROS regulate cell signaling but its role in chondrocyte signaling has not been investigated. In his competitive renewal, we propose to determine the mechanism by which sulfenic acid formation regulates JNK2 activity in chondrocytes. We will determine the role of JNK2 activation in OA in vivo by studying the development of surgically-induced OA in JNK2-/- mice. Finally, we will determine if HB-EGF, upregulated and released when chondrocytes are stimulated by FN-f, promotes Rac activity to activate a co-signaling pathway that augments MMP-13 expression and cartilage matrix destruction. These studies will have significant impact on the field by defining key hubs in a signaling network that mediates cartilage matrix destruction. By discovering novel mechanisms by which ROS regulate this signaling network, the information can be used to develop a unique approach to altering redox-regulated catabolic signaling networks in arthritis that targets specific protein modifications. This represents a significant advance over the general inhibition of ROS production which has not proven successful in treating conditions promoted by excessive ROS, including arthritis.
PUBLIC HEALTH RELEVANCE: Osteoarthritis is the most common cause of chronic disability in older adults but treatments to slow the progression of the disease are lacking. The results from this project will provide new information about basic mechanisms relevant to cartilage breakdown in osteoarthritis. This information is needed in order to discover new targets and develop new therapies for slowing or stopping the progression of the disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying novel osteoarthritis risk genes using GWAS, chondrocyte genomics, and genome editing
-
批准号:10706477
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2022
-
负责人:RICHARD F LOESER
-
依托单位:
Identifying novel osteoarthritis risk genes using GWAS, chondrocyte genomics, and genome editing
-
批准号:10445527
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2022
-
负责人:RICHARD F LOESER
-
依托单位:
The UNC Core Center for Clinical Research: Phenotyping and Precision Medicine Resource Core
-
批准号:10469655
-
项目类别:
-
资助金额:$25.19万
-
财政年份:2019
-
负责人:RICHARD F LOESER
-
依托单位:
The UNC Core Center for Clinical Research: Phenotyping and Precision Medicine Resource Core
-
批准号:10017049
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2019
-
负责人:RICHARD F LOESER
-
依托单位:
The Role of MIF in Osteoarthritis
-
批准号:8839493
-
项目类别:
-
资助金额:$20.27万
-
财政年份:2013
-
负责人:RICHARD F LOESER
-
依托单位:
The Role of MIF in Osteoarthritis
-
批准号:8462375
-
项目类别:
-
资助金额:$23.51万
-
财政年份:2013
-
负责人:RICHARD F LOESER
-
依托单位:
Oxidative Stress and the Development of Osteoarthritis
-
批准号:8840002
-
项目类别:
-
资助金额:$45.77万
-
财政年份:2012
-
负责人:RICHARD F LOESER
-
依托单位:
Oxidative Stress and the Development of Osteoarthritis
-
批准号:8550762
-
项目类别:
-
资助金额:$36.14万
-
财政年份:2012
-
负责人:RICHARD F LOESER
-
依托单位:
Oxidative Stress and the Development of Osteoarthritis
-
批准号:8437793
-
项目类别:
-
资助金额:$39.46万
-
财政年份:2012
-
负责人:RICHARD F LOESER
-
依托单位:
Oxidative Stress and the Development of Osteoarthritis
-
批准号:10659765
-
项目类别:
-
资助金额:$44.4万
-
财政年份:2012
-
负责人:RICHARD F LOESER
-
依托单位:
Oxidative Stress and the Development of Osteoarthritis
-
批准号:10166738
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2012
-
负责人:RICHARD F LOESER
-
依托单位:
Aging and IGF-I in Cartilage
-
批准号:7896945
-
项目类别:
-
资助金额:$0.74万
-
财政年份:2009
-
负责人:RICHARD F LOESER
-
依托单位:
Development Project 3
-
批准号:7646025
-
项目类别:
-
资助金额:$3.93万
-
财政年份:2008
-
负责人:RICHARD F LOESER
-
依托单位:
Integrin Function in Cartilage
-
批准号:7267875
-
项目类别:
-
资助金额:$33.44万
-
财政年份:2007
-
负责人:RICHARD F LOESER
-
依托单位:
Integrin Function in Cartilage
-
批准号:7413459
-
项目类别:
-
资助金额:$31.16万
-
财政年份:2007
-
负责人:RICHARD F LOESER
-
依托单位:
Integrin Function in Cartilage
-
批准号:8117122
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2007
-
负责人:RICHARD F LOESER
-
依托单位:
Integrin Function in Cartilage
-
批准号:7665065
-
项目类别:
-
资助金额:$31.17万
-
财政年份:2007
-
负责人:RICHARD F LOESER
-
依托单位:
Integrin Function in Cartilage
-
批准号:7878077
-
项目类别:
-
资助金额:$31.05万
-
财政年份:2007
-
负责人:RICHARD F LOESER
-
依托单位:
Integrin Function in Cartilage
-
批准号:10228686
-
项目类别:
-
资助金额:$38.64万
-
财政年份:2002
-
负责人:RICHARD F LOESER
-
依托单位:
Integrin Function in Cartilage
-
批准号:6758619
-
项目类别:
-
资助金额:$24.61万
-
财政年份:2002
-
负责人:RICHARD F LOESER
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位:
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: